These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38536656)

  • 1. Development of a diagnostic model for pre-washout screening of primary aldosteronism.
    Wang Q; Dong H; Li HW; Zheng ZH; Liu YZ; Hua YH; Xiong YJ; Zhang HM; Song L; Zou YB; Jiang XJ
    J Endocrinol Invest; 2024 Oct; 47(10):2539-2550. PubMed ID: 38536656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
    Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.
    Ng E; Gwini SM; Libianto R; Choy KW; Lu ZX; Shen J; Doery JCG; Fuller PJ; Yang J
    J Clin Endocrinol Metab; 2022 Dec; 108(1):33-41. PubMed ID: 36179243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of aldosterone/direct renin ratio before drug washout in the screening of primary aldosteronism].
    Ma WJ; Lou Y; Bian J; Cai J; Zhang HM; Zhou XL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(41):3250-3254. PubMed ID: 33167113
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
    Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
    J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
    Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
    BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays.
    Deng L; Xiong Z; Li H; Lei X; Cheng L
    Clin Biochem; 2018 Jun; 56():89-94. PubMed ID: 29684370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
    Douillard C; Houillier P; Nussberger J; Girerd X
    Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.
    Fischer E; Reuschl S; Quinkler M; Rump LC; Hahner S; Bidlingmaier M; Reincke M;
    Horm Metab Res; 2013 Jul; 45(7):526-31. PubMed ID: 23613013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of primary aldosteronism screened from Chinese patients with hypertension: The China primary aldosteronism prospective study.
    Hu Z; Chen X; Cheng YB; Zhong P; Li QA; Zhao Y; Luan H; Ren J; Chen GL; Wang JG
    J Clin Hypertens (Greenwich); 2024 Sep; 26(9):1082-1089. PubMed ID: 39037171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
    Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.